ALS Medication: New Formulation Approved
The US Food and Drug Administration (FDA) has approved a new formulation of riluzole, an ALS medication.
A New Rx for ALS
The US Food and Drug Administration (FDA) has approved a medication to treat amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig’s disease.
Another Danger of Pesticides
Environmental toxins, such as certain pesticides, may be tied to an increased risk for a serious neurodegenerative disease, a new study found.
Blood Pressure Medications May Lower Risk of ALS
ACE inhibitors are often used to treat high blood pressure and heart failure. But new research suggests they may also prevent ALS.
Weight-Gain Diet Safe for ALS Patients
Patients with ALS sometimes consume a high-calorie diet to gain weight and body mass. A recent study investigated whether these diets are safe.
New Med Not the Answer for Lou Gehrig's
A cure for Lou Gehrig's disease has yet to be discovered. As researchers explore possibilities, a new study has shown that what was thought to be a potential new medication for the condition might not be the answer.
NFL Players’ Brain Disease Risk Triple
The NFL season kicked off September 5. The same day, the U.S. Centers for Disease Control and Prevention (CDC) issued a special report about NFL players' deaths from brain diseases.
Smoking Cigarettes May Trigger ALS
It is common knowledge that smoking cigarettes is bad for you. For those with Amyotrophic Lateral Sclerosis (ALS), also known as Lou Gehrig’s disease, smoking can be especially damaging.
Shorter Exam Pinpoints ALS Brain Function Declines
Patients with amyotrophic lateral sclerosis (ALS) might lose brain function before any of their friends or loved ones even notice. This could make it difficult for them to make decisions about their own care.
Game-changing Advance in Stem Cell Science
Stem cell research holds the promise of changing the entire field of medicine. But research has been hampered because scientists haven't found a way to produce enough cells that can be studied safely.